Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination A US Cohort

被引:169
作者
Edelman, Alison [1 ]
Boniface, Emily R.
Benhar, Eleonora
Han, Leo
Matteson, Kristen A.
Favaro, Carlotta
Pearson, Jack T.
Darney, Blair G.
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
关键词
STRESS;
D O I
10.1097/AOG.0000000000004695
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To assess whether coronavirus disease 2019 (COVID-19) vaccination is associated with changes in cycle or menses length in those receiving vaccination as compared with an unvaccinated cohort. METHODS: We analyzed prospectively tracked menstrual cycle data using the application "Natural Cycles." We included U.S. residents aged 18-45 years with normal cycle lengths (24-38 days) for three consecutive cycles before the first vaccine dose followed by vaccine-dose cycles (cycles 4-6) or, if unvaccinated, six cycles over a similar time period. We calculated the mean within-individual change in cycle and menses length (three prevaccine cycles vs first- and second-dose cycles in the vaccinated cohort, and the first three cycles vs cycles four and five in the unvaccinated cohort). We used mixed-effects models to estimate the adjusted difference in change in cycle and menses length between the vaccinated and unvaccinated cohorts. RESULTS: We included 3,959 individuals (vaccinated 2,403; unvaccinated 1,556). Most of the vaccinated cohort received the Pfizer-BioNTech vaccine (55%) (Moderna 35%, Johnson & Johnson/Janssen 7%). Overall, COVID-19 vaccine was associated with a less than 1-day change in cycle length for both vaccine-dose cycles compared with prevaccine cycles (first dose 0.71 day-increase, 98.75% CI 0.47-0.94; second dose 0.91, 98.75% CI 0.63-1.19); unvaccinated individuals saw no significant change compared with three baseline cycles (cycle four 0.07, 98.75% CI -0.22 to 0.35; cycle five 0.12, 98.75% CI -0.15 to 0.39). In adjusted models, the difference in change in cycle length between the vaccinated and unvaccinated cohorts was less than 1 day for both doses (difference in change: first dose 0.64 days, 98.75% CI 0.27-1.01; second dose 0.79 days, 98.75% CI 0.40-1.18). Change in menses length was not associated with vaccination. CONCLUSION: Coronavirus disease 2019 (COVID-19) vaccination is associated with a small change in cycle length but not menses length.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 50 条
  • [21] The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine disorder
    Faraidoon Haghdoost
    Cheryl Carcel
    Deepak Chandrasekhar
    Anthony Rodgers
    Candice Delcourt
    Journal of Neurology, 2021, 268 : 4429 - 4435
  • [22] Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy
    Belli, Oriana
    Ardissino, Maddalena
    Bottiroli, Maurizio
    Soriano, Francesco
    Blanda, Calogero
    Oreglia, Jacopo
    Mondino, Michele
    Moreo, Antonella
    CARDIOVASCULAR ULTRASOUND, 2021, 19 (01)
  • [23] Life and Stress of Japanese Children and Adolescents During the Prolonged Coronavirus Disease 2019 (COVID-19) Pandemic
    Okuyama, Junko
    Seto, Shuji
    Fukuda, Yu
    Ito, Kiyoshi
    Imamura, Fumihiko
    Funakoshi, Shunichi
    Izumi, Shin-Ichi
    JOURNAL OF DISASTER RESEARCH, 2023, 18 (01) : 48 - 56
  • [24] Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy
    Oriana Belli
    Maddalena Ardissino
    Maurizio Bottiroli
    Francesco Soriano
    Calogero Blanda
    Jacopo Oreglia
    Michele Mondino
    Antonella Moreo
    Cardiovascular Ultrasound, 19
  • [25] Mental Health and Related Factors of Adolescent Students During Coronavirus Disease 2019 (COVID-19) Pandemic
    Lu, Tian'ge
    Yu, Yao
    Zhao, Zhonghui
    Guo, Rongjuan
    PSYCHIATRY INVESTIGATION, 2022, 19 (01) : 16 - 28
  • [26] Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?
    El-Hage, W.
    Hingray, C.
    Lemogne, C.
    Yrondi, A.
    Brunault, P.
    Bienvenu, T.
    Etain, B.
    Paquet, C.
    Gohier, B.
    Bennabi, D.
    Birmes, P.
    Sauvaget, A.
    Fakra, E.
    Prieto, N.
    Bulteau, S.
    Vidailhet, P.
    Camus, V
    Leboyer, M.
    Krebs, M-O
    Aouizerate, B.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2020, 46 (03): : S73 - S80
  • [27] Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape
    Mukund, Kavitha
    Nayak, Priya
    Ashokkumar, Chethan
    Rao, Sohail
    Almeda, Jose
    Betancourt-Garcia, Monica M.
    Sindhi, Rakesh
    Subramaniam, Shankar
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study
    Al-Hashel, Jasem Y.
    Ismail, Ismail Ibrahim
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
  • [29] Impacts of the Coronavirus Disease 2019 (COVID-19) pandemic on healthcare workers: A nationwide survey of United States radiologists
    Demirjian, Natalie L.
    Fields, Brandon K. K.
    Song, Catherine
    Reddy, Sravanthi
    Desai, Bhushan
    Cen, Steven Y.
    Salehi, Sana
    Gholamrezanezhad, Ali
    CLINICAL IMAGING, 2020, 68 : 218 - 225
  • [30] Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
    Medvegy, Mihaly
    Simonyi, Gabor
    CARDIOLOGY AND THERAPY, 2021, 10 (01) : 1 - 7